Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use
Aimis to determine the efficacy of Allergoferon® — combined medicine composed of interferon alfa-2b and loratadine gel for topical and external use — in ocular allergies treatment.Materials and methods. 60 patients with allergic eye diseases were treated. Allergoferon® gel applied QID on upper and l...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2014-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/37 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849240728722472960 |
|---|---|
| author | A. V. Surov, A. G. Zaspina |
| author_facet | A. V. Surov, A. G. Zaspina |
| author_sort | A. V. Surov, |
| collection | DOAJ |
| description | Aimis to determine the efficacy of Allergoferon® — combined medicine composed of interferon alfa-2b and loratadine gel for topical and external use — in ocular allergies treatment.Materials and methods. 60 patients with allergic eye diseases were treated. Allergoferon® gel applied QID on upper and lower eyelids was used as a first-line therapy. Efficacy was measured using the following criteria: chemozis, eyelid edema, conjunctival redness and discharge, the presence of conjunctival follicles and papillae. All symptoms were scored using a 4‑point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe).Results. Topical administration of Allergoferon® was associated with significant symptoms reduction, i.e., chemozis by 82 %, eyelid edema by 91 %, conjunctival redness by 79 %, eyelid redness by 88 %, conjunctival discharge by 95 %, the presence of conjunctival follicles and papillae by 76 %.Conclusion. Allergoferon® gel for topical and external use quickly reduces tissue allergic reactions and, consequently, terms of treatment. This medication is highly-effective as a therapy of ocular allergies owing to its antihistamine, anti-inflammatory and anti-exudative effects. |
| format | Article |
| id | doaj-art-5dfd772396e8402e9a7380a5ec6dbfc4 |
| institution | Kabale University |
| issn | 1816-5095 2500-0845 |
| language | Russian |
| publishDate | 2014-07-01 |
| publisher | Ophthalmology Publishing Group |
| record_format | Article |
| series | Oftalʹmologiâ |
| spelling | doaj-art-5dfd772396e8402e9a7380a5ec6dbfc42025-08-20T04:00:27ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452014-07-01111626510.18008/1816-5095-2014-1-62-6537Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external useA. V. Surov,0A. G. Zaspina1Omsk state medical academyOmsk state medical academyAimis to determine the efficacy of Allergoferon® — combined medicine composed of interferon alfa-2b and loratadine gel for topical and external use — in ocular allergies treatment.Materials and methods. 60 patients with allergic eye diseases were treated. Allergoferon® gel applied QID on upper and lower eyelids was used as a first-line therapy. Efficacy was measured using the following criteria: chemozis, eyelid edema, conjunctival redness and discharge, the presence of conjunctival follicles and papillae. All symptoms were scored using a 4‑point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe).Results. Topical administration of Allergoferon® was associated with significant symptoms reduction, i.e., chemozis by 82 %, eyelid edema by 91 %, conjunctival redness by 79 %, eyelid redness by 88 %, conjunctival discharge by 95 %, the presence of conjunctival follicles and papillae by 76 %.Conclusion. Allergoferon® gel for topical and external use quickly reduces tissue allergic reactions and, consequently, terms of treatment. This medication is highly-effective as a therapy of ocular allergies owing to its antihistamine, anti-inflammatory and anti-exudative effects.https://www.ophthalmojournal.com/opht/article/view/37allergic conjunctivitisinterferon alfa-2bloratadineallergoferon |
| spellingShingle | A. V. Surov, A. G. Zaspina Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use Oftalʹmologiâ allergic conjunctivitis interferon alfa-2b loratadine allergoferon |
| title | Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use |
| title_full | Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use |
| title_fullStr | Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use |
| title_full_unstemmed | Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use |
| title_short | Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use |
| title_sort | complex treatment of allergic eye diseases using interferon alfa 2b and loratadine gel for topical and external use |
| topic | allergic conjunctivitis interferon alfa-2b loratadine allergoferon |
| url | https://www.ophthalmojournal.com/opht/article/view/37 |
| work_keys_str_mv | AT avsurov complextreatmentofallergiceyediseasesusinginterferonalfa2bandloratadinegelfortopicalandexternaluse AT agzaspina complextreatmentofallergiceyediseasesusinginterferonalfa2bandloratadinegelfortopicalandexternaluse |